The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Ergomed plc

9 Oct 2023 10:03

RNS Number : 4199P
Numis Securities Limited
09 October 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Ergomed plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Ergomed plc - (Numis is acting as Joint Financial Adviser, Nominated Adviser and Joint Broker to Ergomed plc)

(d) Date dealing undertaken:

06/10/2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Sales

772

1344.0000 GBX

1344.0000 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

09/10/2023

Contact name:

Edward Atkins

Telephone number:

0207 260 1487

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUKRKROUURRRA
Date   Source Headline
2nd Apr 20207:00 amRNSUpdate on Siltuximab Clinical Study
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20204:36 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSErgomed’s PrimeVigilance Supports COVID-19 Trial
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202012:44 pmEQSEdison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
25th Mar 20207:00 amRNSAudited full year results
18th Mar 20208:39 amRNSErgomed Announces COVID-19 Clinical Study
4th Mar 20207:00 amRNSNotice of Preliminary Results
2nd Mar 20207:00 amRNSTotal Voting Rights
18th Feb 20203:19 pmRNSHoldings in Company
14th Feb 20207:00 amRNSDirector/PDMR Shareholding
7th Feb 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Feb 20205:45 pmRNSHoldings in Company
30th Jan 20207:00 amRNSAward of Share Options
30th Jan 20207:00 amRNSExercise of Share Options and Total Voting Rights
29th Jan 20207:00 amRNS2019 Trading Update
20th Jan 20204:13 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSCOO, Lewis Cameron, joins Ergomed
17th Jan 20207:00 amRNSExercise of Options
13th Jan 20207:00 amRNSAcquisition of Ashfield Pharmacovigilance Inc.
2nd Jan 20207:00 amRNSTotal Voting Rights & Block Listing Return
19th Dec 201911:59 amRNSBlock Listing Application
2nd Dec 20197:00 amRNSAppointment of Chief Operating Officer
2nd Dec 20197:00 amRNSTotal Voting Rights
19th Nov 201910:30 amRNSHolding(s) in Company
14th Nov 20195:24 pmRNSHolding(s) in Company
8th Nov 20193:43 pmRNSHolding(s) in Company
8th Nov 20193:41 pmRNSHolding(s) in Company
7th Nov 20197:00 amRNSDirector's Dealing
1st Nov 20194:41 pmRNSSecond Price Monitoring Extn
1st Nov 20194:35 pmRNSPrice Monitoring Extension
1st Nov 20197:00 amRNSTotal Voting Rights
1st Oct 20197:00 amRNSTotal Voting Rights
25th Sep 20197:00 amRNSBoard Change
25th Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSBoard Change
2nd Sep 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSNotice of Interim Results
20th Aug 20197:00 amRNSBoard Appointment
1st Aug 20197:00 amRNSTotal Voting Rights
26th Jul 20193:30 pmRNSHolding(s) in Company
24th Jul 20198:04 amRNSDirector/PDMR Shareholding
23rd Jul 20193:19 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSBoard Appointments
22nd Jul 20197:00 amRNSErgomed H1 2019 Trading Update
19th Jul 20197:05 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSHoldings in Company
10th Jul 20197:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.